Comparative analysis can provide important insights into complex biological systems. As demonstrated in the accompanying paper, translating ribosome affinity purification (TRAP) permits comprehensive studies of translated mRNAs in genetically defined cell populations after physiological perturbations. To establish the generality of this approach, we present translational profiles for 24 CNS cell populations and identify known cell-specific and enriched transcripts for each population. We report thousands of cell-specific mRNAs that were not detected in whole-tissue microarray studies and provide examples that demonstrate the benefits deriving from comparative analysis. To provide a foundation for further biological and in silico studies, we provide a resource of 16 transgenic mouse lines, their corresponding anatomic characterization, and translational profiles for cell types from a variety of central nervous system structures. This resource will enable a wide spectrum of molecular and mechanistic studies of both well-known and previously uncharacterized neural cell populations.
INTRODUCTION
The histological, molecular, and biochemical complexities of the mammalian brain present a serious challenge for mechanistic studies of brain development, function, and dysfunction. To provide a foundation for these studies, we applied several classical principles to the exploration of anatomical and functional diversity in the mouse central nervous system (CNS). First, as exemplified by Ramon y Cajal, detailed comparative analysis of myriad cell types can permit strong inferences about their specific contributions to CNS function (Ramon y Cajal et al., 1899). Second, as demonstrated from invertebrate studies, a deep understanding of the contributions of specific cells to behavior can best be achieved if one has reproducible, efficient genetic access to these cell populations in vivo (Bargmann, 1993; Zipursky and Rubin, 1994) . Third, as illustrated by detailed studies of signal transduction in striatal medium spiny neurons (Greengard, 2001; Svenningsson et al., 2004) , the highly specialized properties of even closely related neurons arise from the combined actions of their many protein components.
Previously, we have broadly applied the BAC transgenic strategy (Heintz, 2004; Yang et al., 1997) to provide high-resolution anatomical data and BAC vectors for genetic studies of morphologically defined cells in the CNS (Gong et al., 2003) . In the accompanying paper (Heiman et al., 2008) , we have reported the development of the TRAP methodology for the discovery of the complement of proteins synthesized in any genetically defined cell population. Here, we describe the generation of additional bacTRAP transgenic mice and translational profiles for 24 distinct cell populations, including all of the major cerebellar cell types. We also demonstrate some of the analytical tools that can be employed for comparative analysis of selected cell types and illustrate as an example of this analysis the many features of spinal motor neurons that can be discovered using this approach.
As anticipated in the studies of Heiman et al. (2008) , this resource will allow molecular phenotyping of CNS cell types at specified developmental stages, and in response to a variety of pharmacological, genetic or behavioral alterations. The mice and data we present here confirm the generality of the TRAP approach and provide an important new resource for studies of the molecular basis for cellular diversity in the mouse brain.
RESULTS

Selection of BAC Drivers to Target Specific CNS Cell Types
As illustrated by Heiman et al. (2008) , the TRAP methodology requires accurate targeting of the EGFP-L10a ribosomal fusion protein to desired CNS cell types and affinity purification of cellspecific polysomal RNAs, which can then be analyzed with microarray technology. We selected BACs reported by the GENSAT project to specifically target a wide range of neurons and glia from different structures throughout the CNS, including BAC drivers expected to target less-well-defined populations (http://www.gensat.org/). BAC transgenic lines generated for the TRAP methodology, with the EGFP-L10a transgene, are referred to here as bacTRAP lines.
Anatomic Characterization of bacTRAP Transgenic Mouse Lines
To ensure that expression of the EGFP-L10a fusion protein is accurate, and to clearly define the cell types to be further analyzed by TRAP, we conducted detailed anatomic studies. For each line, transgene expression was carefully assayed by immunohistochemistry (IHC) with an antibody against enhanced green fluorescent protein (EGFP) (Figure 1 ). The regions covered in this survey include cerebellum (panels 1-9), spinal cord (10), basal forebrain and corpus striatum (11) (12) (13) (14) , brainstem (15), and cerebral cortex (16) (17) (18) (19) (20) (21) (22) (23) (24) (25) .
For well-characterized cell types, confirmation of transgene targeting was straightforward. For example, one can easily identify Purkinje cells (Pcp2, panel 1), granule cells (Neurod1, panel 2), Golgi neurons (Grm2, panel 3), and Bergmann glia (Sept4, panel 8) on the basis of their morphology and position in the cer- ebellum. Two points can be made from this analysis. First, the expression of the EGFP-L10a transgene from each BAC driver is correct, conforming both to the published literature and to the GENSAT atlas. Second, the cytoplasmic distribution of the EGFP-L10a fusion protein, although more limited than that of soluble EGFP, provides sufficient morphological detail to unambiguously identify welldescribed CNS cell types.
However, in many cases, cell identity cannot be assigned by morphology and regional position alone. Therefore, we confirmed the presumed cellular identity using double immunofluorescence (IF) for the EGFP-L10a fusion protein and cell type-specific markers (Figure 2) . In most cases, these studies established that any further analyses would be restricted to a well-defined cell population, such as Purkinje cells (Figure 2B) , Golgi cells ( Figure 2E ), or glial cell types, including astrocytes (Aldh1L1), mature oligodendrocytes (Cmtm5), and a mixed oligodendroglial line that included mature oligodendrocytes and oligodendrocyte progenitors (Olig2) ( Figure S1 available online).
These studies also identified mouse lines in which the transgene is expressed in two or more cell types. For example, the IF analysis of the Lypd6 line ( Figure 2D ) revealed that EGFPL10a is found in all Pvalb-positive and NeuN-negative interneurons of the cerebellar molecular layer, suggesting that this line targets both stellate and basket cells. Also, in certain lines, it is apparent that the transgene is expressed in only a subset of a particular cell type. For instance, in the Grp line, the EGFPL10a fusion protein is restricted to the subpopulation of unipolar brush cells (Nunzi et al., 2002) that are immunoreactive for Grm1 but not Calb2 (calretinin) ( Figure 2F ).
Transgenic lines that express as anticipated from GENSAT, but do not conform to readily identified cell types, were also analyzed by IF analysis to provide data concerning the broad classification of cell populations targeted. For example, in the cerebral cortex of the Cort line, Calb1 was detected in nearly 50% of EGFP-L10a-positive cells, Pvalb was found in less than 5% of these cells, and Calb2 was not detected (data not shown).
In Pnoc bacTRAP mice, the majority of EGFP-L10a-positive cells in the superficial layers of the cerebral cortex were multipolar and GABA positive, although some cells in deeper layers of cortex were GABA negative and appeared to have a single apical dendrite. The multipolar cells in this case were often positive for Calb2 but not Calb1 or Pvalb (data not shown). Both IHC and IF studies of the cortex of the Cck line clearly demonstrate that EGFP-L10a is detected in small neurons positive for Calb1 but not Pvalb or Calb2, as well as in pyramidal cells (data not shown), consistent with previous in situ hybridization (ISH) data (http:// www.stjudebgem.org/; http://www.brain-map.org/) (Lein et al., 2007; Magdaleno et al., 2006) . Unfortunately, good markers are not known for every cell type. For example, the markers for cortical interneurons assayed above have only limited correspondence to physiological properties of the cells (Markram et al., 2004) , and markers for various pyramidal cell populations have not been established. Rather, since the initial studies of Ramon y Cajal et al. (1899) and Lorente de No (1934) , projection neurons in the cerebrum have been identified by their pyramidal shape and broadly classified by their laminar specificity, dendritic arbor, and axonal targets. Accordingly, we have produced lines that clearly label large pyramidal cells of layers 6 (Ntsr1, panel 16), 5b (Glt25d2, panel 17), and 5a (Etv1, panel 18). Although axons were not clearly labeled in these bacTRAP mice, morphometric studies provide additional data indicating that the GENSAT EGFP lines and bacTRAP EGFP-L10a lines target similar cortical pyramidal cell populations ( Figure S2 ). In the corresponding GENSAT lines these cell populations were shown to project to the thalamus (Ntsr1), pons and spinal cord (Glt25d2), and striatum (Etv1) (http:// www.gensat.org/).
It is important to note that in most of the bacTRAP lines, the EGFP-L10a fusion protein is detected in multiple CNS structures. A salient example is the cholinergic cell populations targeted in the Chat lines. In this case, we have clearly demonstrated correct expression in spinal cord motor neurons, neurons of the corpus striatum, basal forebrain projection neurons, brainstem motor neurons (Figure 1 , panels 10, 13, 14, and 15), and neurons of the medial habenula (data not shown). As detailed below, we have collected translational profiles for the first four of these cholinergic cell populations by separately dissecting these regions prior to affinity purification of the EGFP-L10a-tagged polysome populations. Likewise, we assayed the glial cell lines in both cerebellar and cortical tissue. Since specifically expressed genes are often found in distinct cell types from physically separable brain structures, the lines we present here offer opportunities for the study of additional cell types.
Translating Ribosome Affinity Purification, RNA Extraction, and Control Microarray Experiments In total, we identified 24 cell populations in five regions that we chose to assay by TRAP (Heiman et al., 2008) . As shown in Figure S3 , this procedure yielded the purification of EGFPribosomal fusion protein along with cell-specific mRNAs. We also harvested RNA from the unbound (UB) fraction of the immunoprecipitation to measure the genes expressed in the dissected region as a whole.
As shown by Heiman et al. (2008) , and in Figure S4A , replicates for the same cell type gave nearly identical genome-wide translational profiles. The average Pearson's correlation between independent replicates was above 0.98 across all cell types. To determine whether the transgene's integration position would influence the data, we also examined independent bacTRAP lines prepared with the same engineered BAC. This analysis revealed that the variation between independent founder lines was low and no more extensive than it was for replicate samples isolated from the same founder line ( Figure S4D ). Thus, the location of the transgene insertion into the genome had little global impact on the data. Finally, we tested four different custom monoclonal antibodies and one goat polyclonal against EGFP. Each antibody immunoprecipitated comparable levels of mRNA and yielded similar global gene translational profiles (data not shown). Thus, the monoclonal antibodies, a renewable reagent for future TRAP studies, were used for the remainder of the work.
We noticed that a small number of probesets (Table S2 ) are consistently enriched in every data set analyzed. Since these same probesets were also enriched in immunoprecipitates from control mice with no transgene expression, we conclude that they represent background, which we systematically eliminated from further analysis.
Translational Profile Analysis and Confirmation
To provide a measure of the enrichment for each mRNA immunoprecipitated from the targeted cell type (IP) versus its expression in the tissue sample dissected for the analysis (UB), we calculated the ratio of IP/UB. Figure S4B shows scatter plots for three representative cell types of the cerebellum. Dramatic differences are evident between the genome-wide translational profiles of IP samples compared to whole tissue, with each cell population displaying a unique profile of thousands of enriched genes ( Figure S4C ). Venn diagrams of the top 1000 most enriched probesets for each cell type illustrate this point. Thus, approximately 75% of the enriched probesets are not shared between Purkinje cells, granule cells, and unipolar brush cells, and only 52 of the probesets enriched in these three cell types are shared between them. To aid in the use of these lines and allow users to investigate mRNAs in specific CNS cell types, we present IP/UB data for each cell type in Table S5 .
To determine whether this methodology accurately enriched for cell-specific genes, we examined the TRAP microarray data for known markers (positive controls) for each cell type. We also examined genes expressed exclusively in other cell types (negative controls). Figure 3A shows a scatter plot of IP/UB for spinal cord motor neurons. Probesets for markers of motor neurons with measurable signal (green dots) are clearly enriched in the IP sample, whereas probesets for glial-specific RNAs (red dots, negative controls), are clearly enriched in the UB sample. To establish the generality of this finding, we quantified the enrichment by calculating an average ratio of IP/UB for positive and negative controls for each cell type with at least three known markers. As shown in Figure 3B , all IPs showed a clear enrichment for appropriate known markers, ( Figure 3B , plotted in log base 2). Even for cell types with only one known marker (such as Pnoc-or Grp-positive cells), probesets for these genes were consistently enriched in the IP. In the IPs with the lowest relative yield of RNA, such as those for mature oligodendrocytes ( Figure 3B ), and Cort-expressing interneurons (data not shown), background was proportionally higher, and enrichment was less robust. Nonetheless, TRAP microarray data successfully identifies the known markers for these cells as well.
We next attempted to identify novel cell-specific markers for rare cell types. For this, we screened 11 genes predicted by the TRAP data to be enriched in either the Pnoc-expressing cells of the cerebral cortex or Grm2-expressing cerebellar Golgi cells with confocal microscopy for fluorescent ISH and IF for EGFPL10a. For the nine genes where ISH gave clear results, all were clearly overlapping with EGFP-L10a (Figure 3 and data not shown) .
In Golgi cells, there is a high degree of overlap between EGFPL10a expression in the Grm2 line and expression of the ISH analysis ( Figure 3C ). This substantial overlap confirms the specificity of the results we have obtained for this and other cell types. Nonetheless, the enrichment of a particular mRNA in the IP sample cannot be used to conclude that it is expressed in the cell type exclusively or that it is expressed in all cells of that type. For example, consistent with the ISH databases (http://www. stjudebgem.org/; http://www.brain-map.org/), our data clearly indicate that Penk1 is expressed in Golgi cells and in scattered cells in the molecular layer ( Figure 3C , panel 1). Finally, some mRNAs were not detected with the ISH technique, perhaps reflecting limited sensitivity of ISH for genes expressed at moderate levels ( Figure 3C , panel 6).
In order to validate the quantitative aspects of the TRAP microarray datasets, we measured the enrichment of a variety of mRNAs isolated from the Chat (motor neuron) and Pcp2 (Purkinje cell) transgenic lines with quantitative real time PCR (qRT-PCR) ( Figure 3D ). For all of the control genes tested, this methodology confirmed our TRAP results. For genes not previously known to be expressed in a specific cell type, results from qRT-PCR demonstrated that seven out of the eight mRNAs assayed were in fact cell-type enriched. Moreover, despite an inconclusive ISH result ( Figure 3C , panel 6), qRT-PCR validated the expression of Ceacam10 in the cerebellum and its enrichment in Golgi cells ( Figure 3D ). In some cases, therefore, the TRAP methodology appears to be more sensitive than ISH.
Comparative Analysis of TRAP Microarray Data Collected from Many Cell Types
Having established that the microarray data accurately reflect expression of known controls for each cell type and can be confirmed by independent experimental analysis (Heiman et al., 2008) , we were next interested in illustrating the broad properties of these cells that could be inferred from their comparative analysis. We first performed a hierarchical clustering of all 24 IP and six UB samples using the 20% of probesets with the highest coefficient of variation ( Figure 4A ). This unsupervised clustering essentially recapitulates the known biology of CNS cell types. Thus, the three populations of cortical projection neurons are more similar to one another than they are to cortical interneurons, Purkinje cells, or motor neurons. Astroglial TRAP microarray data collected from different regions of the brain are, as expected, more similar to one another and to Bergmann glia than they are to oligodendrocytes. Oligodendroglia are more similar to each other than they are to any neuronal population, etc. These findings support the concept that cells with similar gene expression patterns share similar functions and suggest that analysis of TRAP microarray data will permit the identification of those gene products responsible for the distinguishing characteristics of each cell type.
There are some surprising features to this analysis. Remarkably, the diversity of translational profiles across neuronal types nearly rivals the diversity between neurons and glia. Although related cell subtypes, such as different motor neurons, are clearly tightly clustered, many neuronal types (e.g., Purkinje cells) are not strongly clustered with any other cell type. This suggests that comparative analysis of translational profiles obtained from highly specialized cell types may yield unanticipated insights into their biochemical properties. Finally, individual cell types did not generally cluster tightly with their tissue of origin. In fact, profiles from different brain regions were clustered more closely to each other than to their respective IP samples, suggesting that microarray data produced from dissected regions are significantly less informative than TRAP analysis of individual cell types.
To examine this point in more detail, we compared the data from total cerebellum to that of the individual cerebellar cell types analyzed in this study. As can be seen in Figure 4B , any single cell type has fewer probesets detectable than the whole cerebellar sample, since the whole cerebellar sample represents an aggregate of different cell types. However, the union of the probesets detectable in each of the six individual cerebellar cell types includes over 4000 probesets that are undetectable in the microarray from whole cerebellum. Importantly, these undetectable probesets tend to represent cell type-enriched genes ( Figure 4C ). In fact, for rare cell types, up to 42% of the genes enriched in that cell may not be detectable at all in whole-tissue microarray studies. For detection of genes expressed in specific cell types within complex brain regions, therefore, the TRAP methodology is more sensitive than microarray analysis of dissected brain regions.
The increased sensitivity of the TRAP methodology results in identification of more mRNAs in each cell type, yielding a more complete picture of the translational profile for each cell type or, simply put, more information. To assess whether this increased sensitivity in fact does give better information, we calculated the Shannon entropy for each probeset across the six whole-tissue samples and across the 24 individual cell populations (Fuhrman et al., 2000; Shannon and Weaver, 1969) . Shannon entropy is a measure of information content that describes the complexity of a signal across samples, with values ranging from 0 (low information) to 2 (high information). The average Shannon entropy in cell type-specific experiments (IPs) is over twice as high as that calculated from microarray data of whole-tissue samples ( Figure 5A ) (t test, p < 0.0001, average across all IPs: 0.88 ± 0.002, whole tissue: 0.41 ± 0.003). Examples of probesets with low and high information are shown in Figure 5B . This analysis directly demonstrates that microarray data collected from specific cell types using the TRAP strategy can provide significantly better information than traditional microarray studies of dissected brain tissues.
Using this measure of information, we next classified the 10% of the probesets with either the highest or the lowest entropy ( Figure 5C ) with Gene Ontologies and searched for functional categories that were significantly overrepresented. According to this analysis, cell type diversity in the nervous system is driven primarily by the expression of cell-surface proteins, such as channels and receptors, and also to some extent by the specific expression of transcription factors and calcium-binding proteins. Genes with less information content tend to be those that are more ubiquitously expressed, such as ribosomal and mitochondrial proteins, the expression of which certainly does vary across cell types but much less dramatically than that of receptors and channels.
Comparative analysis of translational profiling across a large number of cell populations may also identify novel coregulated genes that encode the highly specialized properties of individual cell types. To test this, we selected a probeset for a gene known to be involved in myelination-the myelin basic protein (Mbp). We next examined its highest correlates across all samples. In the top 35 genes correlating with Mbp expression (min. correlation, 0.86), we identified six genes also involved in myelination, including Plp1, Cnp, Mog, Mal, and Mobp, and another three genes previously identified in a proteomic screen of myelin components (Table S6 ), in addition to many novel genes that could contribute to myelination. Although this type of correlative (B) Counting detectable (signal >50) probesets in cerebellar samples reveals that although fewer probesets will be detected in any given cell type than are detectable in whole tissue, across all cell types in total, more probesets have measurable signal. Data are normalized to number of probesets in whole cerebellum. Mean ± SD is shown. (C) For four representative cell types, up to 42% of cell-specific or enriched probesets (IP/UB > 2) are undetectable on whole-tissue microarrays. information will become increasingly useful as more TRAP microarray data become available, this experiment provides an illustrative example that the large amount of information we have provided in this study can already be of use for generation of hypotheses concerning the biological functions of poorly studied CNS expressed genes.
Next, to elucidate those genes potentially involved in specifying cell type, we undertook a comparative analysis to identify the most highly specific genes in each population. We performed an iterative comparison: one by one, each sample was compared to each other sample in the data set, and for each population, probesets were sorted by their average ranking across these comparisons. We then combined and clustered by expression the top 100 ranked probesets for each population in a heat map ( Figure 6A ). This illustrates the extent to which distinct cell types are characterized by specific cohorts of genes. For example, none of the top 25 most specific probesets observed in the Purkinje cell sample are found in any of the top 25 most specific probesets for any of the other cell types ( Figure 6B ). In contrast, Drd1 and Drd2 medium spiny neurons, two closely related cell types, coexpress many genes that are not found in the other cell populations analyzed, yet they also express distinct subsets of genes that differentiate them (Heiman et al., 2008) . Thus, comparative analysis of TRAP microarray data can be used to characterize CNS cell populations with very unique biochemical and physiological properties and to distinguish between closely related cell types at the molecular and biochemical level.
As shown in Figure 6B , the top 25 most specific probesets in each cell type include probesets for both well-known cellspecific markers and novel, previously uncharacterized genes. For example, Pcp2, the calcium-binding protein Calb1, the scaffolding and/or synaptic protein Homer3, and the transcription factor Ebf2, all of which are known to be specifically expressed in Purkinje cells (Malgaretti et al., 1997; Shiraishi et al., 2004; Wang et al., 1997) , are among the most highly ranked probesets in the Pcp2 list. Mobp, one of the most abundant components of the CNS myelin sheath (Montague et al., 2006) , is prominent in the Cmtm5 myelinating oligodendrocytes' list. The expression of Tcrb in deep layer cortical neurons (Nishiyori et al., 2004) is confirmed in the Ntsr1 data. The large number of uncharacterized genes with cell-specific translation identified here provides an important resource for discovery of novel biochemical pathways operating in these cell types, or for the identification of new proteins operating in well-known pathways. Finally, comparative analysis can reveal discrepancies that are not apparent from anatomical studies. For example, the most specific probesets for the Etv1 line identify several genes well known to be expressed in lymphoid cells, suggesting that in this line, the EGFPL10a transgene may also be expressed in circulating cells in the CNS vasculature. For this reason, we are currently characterizing additional transgenic lines for corticostriatal neurons. Taken together, the data shown above demonstrate two important strengths of large-scale comparative analyses of TRAP microarray data. First, molecular relationships between cell types can be easily established with hierarchical clustering (Figure 4) ; second, groups of genes that encode the biochemical functions of specific cell types can be identified via this sort of systematic comparative approach (Figure 6 ).
Analysis of TRAP Microarray Data Collected from Spinal Motor Neurons
Because of their involvement in a variety of serious neurological disorders and severe, acute injuries, spinal cord motor neurons (MNs) have been extensively studied, and a wealth of anatomical, molecular, and physiological data exist for them. This fact has allowed us to compare the TRAP microarray data presented here with the published literature. As shown in Figure 7 , in a single TRAP experiment, we can rediscover most of the MN-expressed molecules that have been documented in prior studies. In most cases, where microarray probesets were present and informative, the microarray results agree well with the literature. Thus, it has been reported that MNs express glutamate receptors sensitive to AMPA, kainate, and NMDA (Rekling et al., 2000) . Our results suggest that the specific receptor subunits mediating these responses include Gria3 and 4, Grik2 and 4, and Grin1, 3a, and 3b. Inhibition in MNs should be due the actions of the Glra2 and Glrb glycine receptor subunits and both metabotropic (Gabbr1) and ionotropic GABAergic receptors, potentially composed of Gabra2, a5, and b3 subunits. Our data predict that MNs should respond to all classic neurotransmitters, including acetylcholine, via Chrna4/b2 and/or Chrna7 receptors, and serotonin, via the Htr1d receptor. In disagreement with prior immunohistochemical findings (Rekling et al., 2000) , we do not detect the expression of Drd1 and or Drd2 in MNs. Moreover, our transgenic mice for Drd1 and Drd2 do not show transgene expression in MNs, nor does the Allen Brain Atlas ISH show expression in brain stem MNs, supporting the microarray results.
MNs also express a variety of newly characterized receptors and orphan receptors. For example, our TRAP data have successfully identified Grin3b as a MN-specific gene encoding an NMDA subunit. This receptor was recently characterized as creating a unique glycine gated channel in MNs (Nishi et al., 2001) . We have also identified several other genes enriched in MNs that potentially encode for MN-specific receptors that either have not been previously characterized in MNs or are entirely unstudied. Two that are particularly interesting are the vitamin D receptor ( Figure S5 ) and the orphan receptor P2rxl1 (Figure 7) . Future studies investigating the role of these receptors in MN behavior may explain cases of reversible muscle weakness in patients with vitamin D deficiency (Ziambaras and Dagogo-Jack, 1997) or suggest new pathways important to MN function. An important caveat to these conclusions, as highlighted by our ISH studies of Grm2-positive neurons of cerebellum, is that these array results reflect the average expression of all the cholinergic cells of the spinal cord-some of the receptors listed in Figure 7 may be expressed in separate pools of cholinergic cells.
Perspectives
In this study, we have extended the findings of Heiman et al. (2008) demonstrating that it allows robust and reproducible isolation of mRNA across a variety of regions and cell types. The method correctly identifies known cell-specific and enriched transcripts for the 24 lines reported here and reports the comprehensive translational profiles for each of them. These profiles identify thousands of novel cell-specific mRNAs that are not detectable by whole-tissue microarray analysis. We have provided a primary analysis of many previously uncharacterized neurons and glia and shown that much of the diversity of the nervous system is driven by the suite of proteins expressed on the surface of specific cell types. To illustrate the depth of the available information, we examined in detail the profile of the spinal cord motor neurons with regard to the receptors they produce and the ligands they secrete, as these are genes that determine the responsiveness of a cell to its environment and the behavior of the cell within a circuit. These data demonstrate that a single TRAP experiment can confirm the findings of decades of geneby-gene expression studies while at the same time identifying a vast number of novel genes that may be essential for motor neuron function.
Further Applications of the bacTRAP Transgenic Mouse Lines
It is important to note that with these 16 initial mouse lines, there are additional cell populations from which TRAP microarray data could be collected. For example, the EGFP-L10a transgene is strongly expressed in CA1 neurons in the Cck line, as well as in the substantia nigra of the Ntsr1 line. Additional studies of these and other uncharacterized populations could provide important information for a variety of critical CNS cell types. Given the presence of the EGFP-L10a fusion protein in dendrites and axons of some of the cell types presented here, it would also be interesting to combine laser-capture microdissection and TRAP to identify translated mRNAs that are localized to specific subcellular compartments.
Beyond the initial characterization we have reported here, there are a variety of biological applications for these bacTRAP lines that are of significant interest. As established by Heiman et al. (2008) , the TRAP strategy can be used as a sensitive method to detect changes in single-cell populations due to whole-animal pharmacological manipulations. Related studies could readily be conducted to assess the cell-specific translational profile across development, in aging, after injury, or in response to behavioral manipulations and genetic perturbations. For example, bacTRAP mice can be readily crossed with knockout mice modeling human diseases, particularly those that impact clearly defined cell types, such as Purkinje cells in some cerebellar ataxias, or oligodendrocytes in multiple sclerosis. In other diseases or conditions such as stroke, which can broadly impact neurons, astrocytes, and oligodendrocytes, the responses of each cell type can be parsed individually by assessing selected bacTRAP lines. This technology will allow us to systematically answer fundamental biological questions regarding the magnitude and particulars of changes in mRNA translation consequent to whole-animal manipulations.
Further Applications of the TRAP Microarray Data
In addition to the available lines, the data from these 24 cell types provide a resource for a variety of studies. The most direct result available from the analysis across these cell types is the identification of novel cell-specific markers. Even the data we present from mixed cell populations can be useful. For example, the Data from MN BACarrays were directly compared to available data for classical neurotransmitters. To perform this analysis, we color coded microarray results as ''expressed,'' ''enriched,'' or ''not expressed.'' This classification was then compared to results reported in the adult rodent literature, color coded simply as either ''expressed'' or ''not expressed'' or left uncolored in cases where there were no studies or conflicting data. IP/UB, fold change versus whole spinal cord for expressed genes. RF, expression data from published rodent literature: 1, Rekling et al. (2000) ; 2, Nishi et al. (2001); 3, Berthele et al. (1999); 4, Towers et al. (2000) ; 5, Malosio et al. (1991); and 6, KaelinLang et al. (1999) .
Grp TRAP data clearly identify mRNAs expressed in both unipolar brush cells and Bergmann glial, as we would predict from the anatomic characterization of this line. Comparative analysis of these data with those obtained from the Sept4 line allows us to subtract Bergmann glial cell mRNAs from these data and identify additional mRNAs specific to unipolar brush cells in order to uniquely target these cell types for second-generation TRAP studies. Furthermore, in cases of relatively weakly expressing lines, such as Cmtm5, new drivers can be selected to more effectively target the same cell type. Indeed, preliminary studies with a new mature oligodendrocyte line (Cnp JD368) have demonstrated improved RNA yield and data quality from a more strongly expressing transgene ( Figure S6 ). In addition, TRAP microarray data can be used to identify suites of candidate epitopes for cross-species comparisons to examine the evolution of the distribution of cell-types in species from mouse through primates.
A number of sophisticated analytical methods have been applied with some success to traditional microarray data sets in order to infer complex biological information from gene expression data. For instance, there are now a variety of approaches to identify transcriptional regulatory networks and novel transcription factor binding sites from microarray data in yeast or cell culture (Blais and Dynlacht, 2005) . In higher organisms, however, these analyses are complicated by the cellular complexity of the tissue samples involved, thus confounding the elucidation of ''coexpressed'' genes. This type of analysis should therefore benefit from the collection of numerous cell type-specific data sets. For the same reason, the use of the TRAP methodology should enhance the search for functional ''modules'' of genes in the CNS (Oldham et al., 2006) . The combination of these analytical methods with our cell type-specific TRAP microarray data sets should significantly enhance our understanding of global gene expression patterns within the CNS. We believe, because of the enhanced information content, that TRAP and other cell-specific technologies should become the standard for microarrays in neuroscience. To this end, we have generated this TRAP resource.
TRAP Resources
The resources we provide here include 16 bacTRAP transgenic lines expressing the EGFP-L10a fusion protein in well-characterized cell types, an anatomic database showing serial coronal sections of EGFP-L10a fusion protein expression in the adult mouse brain, IPvUB data sets for 24 cell types listing all mRNAs enriched in that cell type, detailed protocols for conducting TRAP experiments from the brain, and anti-EGFP monoclonal antibodies. This resource provides the materials, data, and knowledge to enable a wide variety of studies not previously available to the neuroscience community.
EXPERIMENTAL PROCEDURES
BAC Modification, Transgenesis, and Animal Husbandry All protocols involving animals were approved by the Rockefeller University Institute Animal Care and Use Committee. BACs from Table S1 were modified as described to insert an EGFP-L10a fusion protein into the translation start site of the driver gene (Gong et al., 2002; Gong et al., 2003) . Founders and subsequent generations were bred to either Swiss-Webster or c57bl/6 wild-type mice. Lines were maintained as transheterozygotes.
Immunoprecipitation of Polyribosomes
All immunoprecipitations, except for the Drd1 and Drd2 lines, which used the goat anti-EGFP described in the accompanying paper (Heiman et al., 2008) , were done with a mix of two monoclonal antibodies (19C8, 19F7) . Three to six mice for each replicated sample were euthanized with CO 2 , and distinct brain regions were dissected. Each cell population was assayed in triplicate. RNA quantity and quality were determined with a Nanodrop 1000 spectrophotometer (Wilmington, DE) and Agilent 2100 Bioanalyzer (Foster City, CA). For each sample, 15 ng of total RNA was amplified with the Affymetrix two-cycle amplification kit and hybridized to Affymetrix 430 2.0 microarrays according to the manufacturer's instructions.
Histological Methods
Brains were processed identically with MultiBrain Technology (NSA, NeuroScience Associates, Knoxville, TN) for DAB IHC with a 1:75,000 dilution of Goat anti-EGFP serum (Heiman et al., 2008) according to the Vectastain elite protocol (Vector Labs, Burlingame, CA). Serial sections were digitized with a Zeiss Axioskop2 microscope at 103 magnification.
For IF, sections were blocked with 5% normal donkey serum and 0.25% triton and then incubated with primary antibodies (Table S7 ) and appropriate Alexa dye-conjugated secondary antibodies (Molecular Probes/Invitrogen, Carlsbad, CA). Probes for ISH were prepared from EST clones (Open Biosystems, Table S3 ) with the DIG RNA labeling kit (Roche, Basel, Switzerland) and purified with ProbeQuant G-50 microcolumns (GE Healthcare). Twenty micron fixed brain sections were treated with 0.05% Triton X-100 and 50 ug/ml Proteinase K and acetylated (0.1 M triethanolamine, 0.25% acetic anhydride). Sections were prehybridized (500 ug/ml salmon sperm DNA, 2.53 Denhardt's, 53 sodium chloride sodium citrate [SSC] ), hybridized overnight with riboprobe, rinsed (53 SSC, 65 C), and washed for 1 hr (0.23 SSC, 68 C). Development with HNPP and fast red followed manufacturer's protocols (Roche), with the addition of goat anti-EGFP and alexa-488 donkey anti-goat (Invitrogen) for IF. Images were acquired as Z stacks (2 mm sections) with a Zeiss Inverted LSM 510 confocal microscope.
Microarray Normalization and Analysis
In brief, samples were normalized with GCRMA and filtered to remove probesets with low signal and those identified as background (Table S2) . Each IP was compared to unbound samples from the same tissue to calculate a ratio of IP/UB as a measure of ''enrichment.'' Analyzed data for each cell type are available in Table S5 , which contains the IP/UB values for all genes with fold change greater than 2 and p < 0.05 by Welch's t test, with Benjamini and Hochberg false discovery rate (FDR) multiple testing correction. Three cell types were further corrected to remove signal from minor cell types described in Figure 2A (Supplemental Experimental Procedures). Hierarchical clustering and Pearson's correlation with MBP were performed in Genespring 7.0 (Agilent technologies). Shannon entropy was calculated in Excel from GCRMA-normalized values with published formulas (Schneider, 2007) . Gene Ontologies was performed with the BiNGO plugin for the cytoscape software (Maere et al., 2005) . Comparative anlaysis of all cell types, and heat maps (Figure 6 ), were generated with the R stastistical software. A full description of analytical methods is in the Supplemental Data. MIAME-compliant raw data are available from Gene Expression Omnibus.
Quantitative Real-Time RT-PCR cDNA was synthesized from 20 ng of total RNA from the three replicate IP and UB samples with M-MulV reverse transcriptase (New England Biolabs, Ipswich, MA), with oligo dT 23 VN as a primer, and then purified with the QIAGEN Quick PCR cleanup, according to the manufacturer's instructions (QIAGEN, Valencia, CA) . PCR was performed with Biorad iQ syber green supermix according to the manufacturer's protocols (Biorad, Hercules, CA), with 500 nm final concentration of each primer (Table S4 ). Cycling and quantitation were performed with Biorad iQ5 multiplex real-time detection hardware. PCR was carried out for 45 cycles (94 C, 30 s, 63 C, 30 s, 72 C, 30 s), followed by a melt curve.
Each replicate was assayed in triplicate. Conditions yielding significant dimers, as demonstrated by melt curve and/or gel electrophoresis, were excluded from further analysis. Primers that did not yield product in at least two of three replicates prior to 35 cycles were excluded from further analysis. Data were normalized to ActB with the ddCT method, via iQ5's optical system software version 2, and averaged across replicates. All qPCR products were subcloned and sequenced to confirm accuracy of PCR. Microarray data were also normalized to ActB for comparison purposes (Figure 3) .
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